Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum
29 avr. 2021 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central...